When times got tough, the biopharma industry hit the Zoom button and kept things moving at a multibillion-dollar clip
Hot shots named in Trump’s Warp Speed drive for coronavirus vaccine
FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’
Attack of zombie companies: don't let them eat bailouts that are vital to restore the economy
U.S. awards new contract for potential COVID-19 vaccine
Inflation or stagnation? The long and short in fixed income ETFs
Oxford Biomedica signs COVID-19 vaccine supply deal with AZ
Hong Kong unrest pushes dollar higher
UK okays early access to Gilead’s remdesivir in seriously ill COVID-19 patients
Oxford Uni coronavirus vaccine ‘has 50% chance of success’
Earnings still matter
Guest Contribution: “Global bond market contagion in times of Covid-19”
Money Supply Growth in April Ballooned to a New High
The US to waste coronavirus stimulus money on fossil fuels
Federal Reserve KaPow-ells Markets
Can Monopoly Money Save the Stock Market? Or Will It Buy Stagnation?
DAX attacks 11,000 on COVID-19 treatment hopes - sustainable?
Top 10 largest foreign holders of the US treasury securities
3 Big Dividend Stocks Yielding at Least 10%; Maxim Says ‘Buy’
Asia Finding Love On The Rebound
Novogratz Alludes Stimulus Causing Recent Bitcoin Uptrend
After WTI Crude Oil traded in negative territory – is 10,000 USD a possibility in Gold?
Markets Pricing In A Viral All Clear
A Summary Of Warren Buffett’s Berkshire Hathaway Meeting 2020
Mid-Market Update: Reopening doubts and US-China tensions sink risk, Buffett loves cash and abandons airlines, Oil’s dance, Gold’s weak rally
UPDATED: FDA cheers on Gilead's remdesivir with a snap emergency OK, giving biopharma a shot at redemption
Gilead Says Remdesivir Will Be Available To Patients This Week